Several tau transgenic (Tg) mouse models have been generated (Götz et al., 2001; Yanamandra et al., 2015) to explain the pathogenic mechanisms of tau and to assess the efficacy of therapeutic targets for Alzheimer’s disease and FTLD. The gene discussed is MAPT; the disease is Alzheimer disease.